# MoonLake Immunotherapeutics: Form 8-K, filed Sep 1, 2023

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2023-09-01
- Accepted by EDGAR: Sep 1, 2023, 17:00 ET
- Period: 2023-08-30
- Accession: 0001213900-23-073296
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390023073296/ea184508-8k_moonlake.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390023073296/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390023073296/ea184508-8k_moonlake.htm

Filed Sep 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-073296. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
